Raymond Vallera
Gastroenterology · Irving, TXNPI 1922084888
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 203 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 21 manufacturers reported payments, led by AbbVie at 38.4% of the total. 2023 is the largest year on record at $1,310, 3.8 times the $341 reported in 2019. That places this record below the midpoint for gastroenterology clinicians in TX, where the typical reported total is $3,104.
Across 203 payments — averaging $16.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$637
- Takeda Pharmaceuticals U.S.A., Inc.$332
- Johnson & Johnson$240
- Merck$155
- Intercept Pharmaceuticals, Inc.$92
- plus $638 from 15 others
What the payments were for
- Food & beverage$3,397100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 83 | $1,303 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 42 | $637 |
| Takeda Pharmaceuticals U.S.A., Inc. | 17 | $332 |
| Johnson & Johnson(2 entities) | 14 | $240 |
| Merck | 8 | $155 |
| Intercept Pharmaceuticals, Inc. | 4 | $92 |
| Bristol Myers Squibb | 6 | $84 |
| Regeneron Healthcare Solutions, Inc. | 3 | $66 |
| Ferring Pharmaceuticals Inc. | 3 | $64 |
| Sanofi | 2 | $61 |
| Ironwood Pharmaceuticals, Inc | 3 | $59 |
| Daiichi Sankyo Inc. | 3 | $56 |
| Pfizer | 3 | $52 |
| Nestle Healthcare Nutrition Inc. | 3 | $41 |
| Ardelyx, Inc. | 2 | $38 |
| Evoke Pharma, Inc. | 2 | $36 |
| Redhill Biopharma Inc. | 1 | $22 |
| AstraZeneca | 1 | $17 |
| Braintree Laboratories, Inc. | 1 | $15 |
| Organon | 1 | $14 |
| Endogastric Solutions, Inc | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Humira$108
How this compares
$3,397 in reported general payments places this provider in the 50th percentile of 1,350 gastroenterology providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pantoprazole Sodium | 51 | $513 |
| Omeprazole | 13 | $232 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in Irving
- Jayaprakash SreenarasimhaiahIrving$71K
- John FordtranDallas$9.9M
- Michael BrownDallas$5.5M
- Bincy AbrahamHouston$1.6M
- Mazen NoureddinHouston$1.5M
- Stephen PappasHouston$1.4M
- Anish PatelFort Sam Houston$1.3M
- Timothy RitterSouthlake$961K
- Parvez MantryDallas$958K
- Nadege GunnWaco$933K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.